<DOC>
	<DOCNO>NCT01260857</DOCNO>
	<brief_summary>Aldazide 25 mg OD give Filipino hypertensive patient , 2 follow-up visit week 4 week 8 monitor safety efficacy primary secondary outcome , respectively .</brief_summary>
	<brief_title>Safety And Efficacy Of Spirinolactone Plus Hydroflumethiazide In The Treatment Of Filipino Patients With Hypertension</brief_title>
	<detailed_description>Prospective , non-interventional non-probability sampling</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydroflumethiazide</mesh_term>
	<criteria>Patients &gt; /= 18 year old Stage 1 2 hypertension control monotherapy combination antihypertensive without diuretic yet . Pregnant lactate woman , hypersensitivity Aldazide , patient resistant hypertension control combination therapy diuretic regimen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Spirinolactone</keyword>
	<keyword>Hydroflumethiazide</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Filipinos</keyword>
	<keyword>Diabetes mellitus</keyword>
	<keyword>Proteinuria</keyword>
</DOC>